247
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Clinical Characteristics and Prognosis of Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study

, , , , , , , , , , ORCID Icon & show all
Pages 53-62 | Published online: 12 Jan 2022

References

  • Tracy MC, Okorie CUA, Foley EA, Moss RB. Allergic bronchopulmonary aspergillosis. J Fungi. 2016;2(2). doi:10.3390/jof2020017
  • Agarwal R, Sehgal IS, Dhooria S, et al. Allergic bronchopulmonary aspergillosis. Indian J Med Res. 2020;151(6):529–549. doi:10.4103/ijmr.IJMR_1187_19
  • Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–873. doi:10.1111/cea.12141
  • Shen H, Sun Y, Lin Q, et al. Expert consensus on allergic bronchopulmonary aspergillosis developed by the Asthma Group of the respiratory division of the Chinese medical college of China. Zhonghuayixuezazhi. 2017;97(34):2650–2656.
  • Agarwal R. Burden and distinctive character of allergic bronchopulmonary aspergillosis in India. Mycopathologia. 2014;178:447–456. doi:10.1007/s11046-014-9767-z
  • Lee YB, Kim YS, Lee DH, et al. Association between HOMA-IR and lung function in Korean young adults based on the Korea national health and nutrition examination survey. Sci Rep. 2017;7(1):11726. doi:10.1038/s41598-017-11337-3
  • Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;5(12):e15346. doi:10.1371/journal.pone.0015346
  • Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med. 2010;104(2):204–210. doi:10.1016/j.rmed.2009.09.005
  • Kumar R, Chopra D. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. J Asthma. 2002;39(6):473–477. doi:10.1081/jas-120004905
  • Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med. 2012;106(7):942–947. doi:10.1016/j.rmed.2012.03.001
  • Gernez Y, Waters J, Mirkovic B, et al. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J. 2016;47(1):177–185. doi:10.1183/13993003.01068-2015
  • Guo X, Liu K, Liu Y, et al. Clinical and genetic characteristics of cystic fibrosis in Chinese patients: a systemic review of reported cases. Orphanet J Rare Dis. 2018;13(1):224. doi:10.1186/s13023-018-0968-2
  • Zhang T, Tian X, Xu K-F. Cystic fibrosis: a rare disease emerging in China. Sci China Life Sci. 2020;63(7):1082–1084. doi:10.1007/s11427-020-1620-x
  • Agarwal R, Aggarwal AN, Garg M, Saikia B, Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses. 2014;57(11):659–663. doi:10.1111/myc.12214
  • Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147(4):1261–1268 e5. doi:10.1016/j.jaci.2020.08.029
  • Muthu V, Sehgal IS, Prasad KT, et al. Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: a distinct subset of ABPA with a lesser risk of exacerbation. Med Mycol. 2020;58(2):260–263. doi:10.1093/mmy/myz051
  • Agarwal R, Muthu V, Sehgal IS, et al. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2021. doi:10.1183/13993003.01787-2021
  • Li JX, Fan LC, Li MH, Cao WJ, Xu JF. Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature. Respir Med. 2017;122:33–42. doi:10.1016/j.rmed.2016.11.019
  • Soeda S, Kono Y, Tsuzuki R, et al. Allergic bronchopulmonary aspergillosis successfully treated with benralizumab. J Allergy Clin Immunol. 2019;7(5):1633–1635.
  • Mümmler C, Kemmerich B, Behr J, Kneidinger N, Milger KA-O. Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab? Allergy Asthma Clin Immunol. 2020;16(1):1–4. doi:10.1186/s13223-020-00454-w
  • Knutsen AP, Bush RK, Demain JG, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol. 2012;129(2):280–91;quiz 292–3. doi:10.1016/j.jaci.2011.12.970